Kenneth MacLean
Concepts (460)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Homocystinuria | 14 | 2024 | 71 | 6.160 |
Why?
| | Cystathionine beta-Synthase | 22 | 2024 | 71 | 4.760 |
Why?
| | Taurine | 6 | 2020 | 46 | 2.570 |
Why?
| | Liver | 16 | 2024 | 1943 | 2.300 |
Why?
| | Betaine | 10 | 2024 | 73 | 2.300 |
Why?
| | Homocysteine | 12 | 2024 | 156 | 1.680 |
Why?
| | Betaine-Homocysteine S-Methyltransferase | 2 | 2019 | 11 | 0.990 |
Why?
| | Oxidation-Reduction | 6 | 2024 | 1060 | 0.950 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2024 | 23 | 0.890 |
Why?
| | Tetrahydrofolates | 1 | 2024 | 18 | 0.890 |
Why?
| | Methionine | 4 | 2021 | 160 | 0.860 |
Why?
| | Down Syndrome | 10 | 2023 | 496 | 0.820 |
Why?
| | Disease Models, Animal | 21 | 2024 | 4295 | 0.790 |
Why?
| | Mice | 42 | 2024 | 17787 | 0.730 |
Why?
| | Mice, Inbred C57BL | 21 | 2024 | 5757 | 0.670 |
Why?
| | Cysteine | 4 | 2020 | 204 | 0.660 |
Why?
| | Fatty Liver | 6 | 2013 | 243 | 0.610 |
Why?
| | Sulfur | 2 | 2014 | 58 | 0.600 |
Why?
| | Sulfinic Acids | 1 | 2018 | 7 | 0.570 |
Why?
| | Choline | 2 | 2017 | 127 | 0.570 |
Why?
| | Sulfhydryl Compounds | 2 | 2018 | 189 | 0.560 |
Why?
| | Aminobutyrates | 1 | 2018 | 35 | 0.560 |
Why?
| | Animals | 48 | 2024 | 36940 | 0.550 |
Why?
| | Pyruvaldehyde | 1 | 2018 | 46 | 0.550 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2017 | 8 | 0.540 |
Why?
| | Endoplasmic Reticulum | 5 | 2014 | 265 | 0.530 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2024 | 279 | 0.480 |
Why?
| | Cystathionine | 2 | 2012 | 24 | 0.480 |
Why?
| | Phospholipids | 1 | 2017 | 223 | 0.470 |
Why?
| | Mice, Knockout | 10 | 2020 | 3015 | 0.460 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2021 | 36 | 0.460 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2023 | 248 | 0.460 |
Why?
| | Abnormalities, Multiple | 3 | 2007 | 189 | 0.450 |
Why?
| | Apolipoprotein A-I | 2 | 2012 | 30 | 0.450 |
Why?
| | Hepatocytes | 3 | 2024 | 220 | 0.440 |
Why?
| | Thrombosis | 2 | 2011 | 371 | 0.430 |
Why?
| | Neural Stem Cells | 4 | 2023 | 156 | 0.420 |
Why?
| | Apolipoproteins A | 1 | 2012 | 19 | 0.380 |
Why?
| | Aryldialkylphosphatase | 1 | 2012 | 18 | 0.380 |
Why?
| | Fragile X Syndrome | 2 | 2009 | 77 | 0.360 |
Why?
| | Mice, Transgenic | 10 | 2021 | 2167 | 0.360 |
Why?
| | Folic Acid | 2 | 2024 | 186 | 0.360 |
Why?
| | Mutation | 9 | 2024 | 3958 | 0.340 |
Why?
| | Chemokines | 1 | 2011 | 228 | 0.330 |
Why?
| | Hydrogen Sulfide | 2 | 2020 | 44 | 0.330 |
Why?
| | Trans-Activators | 3 | 2007 | 398 | 0.320 |
Why?
| | Transcription Factors | 9 | 2013 | 1719 | 0.320 |
Why?
| | Hyperglycinemia, Nonketotic | 2 | 2024 | 51 | 0.310 |
Why?
| | S-Adenosylmethionine | 6 | 2006 | 54 | 0.290 |
Why?
| | Male | 34 | 2024 | 67762 | 0.290 |
Why?
| | Endoplasmic Reticulum Stress | 3 | 2014 | 110 | 0.290 |
Why?
| | Biomarkers | 2 | 2019 | 4149 | 0.280 |
Why?
| | Dietary Supplements | 4 | 2014 | 561 | 0.280 |
Why?
| | Lipids | 1 | 2012 | 672 | 0.280 |
Why?
| | Urination Disorders | 1 | 2007 | 13 | 0.270 |
Why?
| | Ectodermal Dysplasia | 1 | 2007 | 19 | 0.270 |
Why?
| | Apoptosis | 3 | 2013 | 2553 | 0.270 |
Why?
| | Saccharomyces cerevisiae | 2 | 2002 | 557 | 0.260 |
Why?
| | Cleft Lip | 1 | 2007 | 52 | 0.260 |
Why?
| | Fingers | 1 | 2007 | 88 | 0.260 |
Why?
| | Myoblasts | 1 | 2007 | 84 | 0.260 |
Why?
| | Cleft Palate | 1 | 2007 | 68 | 0.250 |
Why?
| | Protein Precursors | 1 | 2007 | 134 | 0.250 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2021 | 283 | 0.250 |
Why?
| | Metabolome | 2 | 2021 | 350 | 0.250 |
Why?
| | DNA-Binding Proteins | 4 | 2007 | 1502 | 0.240 |
Why?
| | Oxidative Stress | 6 | 2022 | 1317 | 0.240 |
Why?
| | Cystathionine gamma-Lyase | 3 | 2020 | 13 | 0.240 |
Why?
| | Carbon | 2 | 2024 | 216 | 0.240 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2007 | 218 | 0.240 |
Why?
| | Eye Abnormalities | 1 | 2005 | 13 | 0.230 |
Why?
| | Amino Acids | 2 | 2020 | 497 | 0.230 |
Why?
| | Tooth Abnormalities | 1 | 2005 | 13 | 0.230 |
Why?
| | Chromosomes, Human, Pair 6 | 1 | 2005 | 52 | 0.230 |
Why?
| | Tumor Suppressor Proteins | 1 | 2007 | 327 | 0.230 |
Why?
| | Trisomy | 4 | 2017 | 80 | 0.230 |
Why?
| | Chromosome Deletion | 1 | 2005 | 115 | 0.220 |
Why?
| | Phenotype | 5 | 2024 | 3196 | 0.220 |
Why?
| | Sp1 Transcription Factor | 1 | 2003 | 24 | 0.220 |
Why?
| | Humans | 40 | 2024 | 137585 | 0.210 |
Why?
| | Female | 24 | 2024 | 73304 | 0.210 |
Why?
| | Face | 1 | 2005 | 173 | 0.210 |
Why?
| | Nuclear Proteins | 2 | 2013 | 712 | 0.200 |
Why?
| | Glycine | 1 | 2024 | 176 | 0.200 |
Why?
| | Uterine Artery | 2 | 2020 | 79 | 0.190 |
Why?
| | Myocytes, Cardiac | 1 | 2007 | 526 | 0.190 |
Why?
| | Connective Tissue | 1 | 2002 | 36 | 0.190 |
Why?
| | Cells | 1 | 2002 | 25 | 0.190 |
Why?
| | Diet, High-Fat | 2 | 2024 | 247 | 0.190 |
Why?
| | Adenosylhomocysteinase | 1 | 2021 | 10 | 0.180 |
Why?
| | Glycine Hydroxymethyltransferase | 1 | 2021 | 16 | 0.180 |
Why?
| | Heme | 2 | 2002 | 78 | 0.180 |
Why?
| | Polyamines | 1 | 2021 | 40 | 0.170 |
Why?
| | Stress, Psychological | 1 | 2009 | 1100 | 0.170 |
Why?
| | tau Proteins | 2 | 2012 | 90 | 0.170 |
Why?
| | Insulin Resistance | 2 | 2024 | 1208 | 0.170 |
Why?
| | Liver Failure | 1 | 2021 | 94 | 0.170 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 11 | 0.170 |
Why?
| | Lipotropic Agents | 2 | 2012 | 5 | 0.170 |
Why?
| | Quinone Reductases | 1 | 2020 | 17 | 0.170 |
Why?
| | Leigh Disease | 1 | 2020 | 21 | 0.170 |
Why?
| | Mutation, Missense | 1 | 2002 | 341 | 0.170 |
Why?
| | Myometrium | 1 | 2020 | 39 | 0.160 |
Why?
| | Association Learning | 2 | 2011 | 61 | 0.160 |
Why?
| | Lipogenesis | 3 | 2019 | 61 | 0.160 |
Why?
| | Mitochondria | 3 | 2023 | 948 | 0.160 |
Why?
| | Ethanol | 2 | 2016 | 608 | 0.160 |
Why?
| | Growth Differentiation Factor 10 | 1 | 2019 | 1 | 0.160 |
Why?
| | SNARE Proteins | 1 | 2019 | 39 | 0.160 |
Why?
| | Umbilical Arteries | 1 | 2020 | 55 | 0.160 |
Why?
| | Interleukin-1beta | 2 | 2011 | 372 | 0.160 |
Why?
| | Cell Differentiation | 6 | 2023 | 1991 | 0.150 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 176 | 0.150 |
Why?
| | Hyperhomocysteinemia | 2 | 2009 | 27 | 0.150 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 261 | 0.150 |
Why?
| | Glutathione | 3 | 2020 | 356 | 0.150 |
Why?
| | PPAR gamma | 1 | 2019 | 182 | 0.140 |
Why?
| | Recombinant Proteins | 2 | 2001 | 1353 | 0.140 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 43 | 0.140 |
Why?
| | Brachial Artery | 1 | 2019 | 205 | 0.140 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 69 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2011 | 1242 | 0.140 |
Why?
| | Proteostasis Deficiencies | 1 | 2017 | 5 | 0.140 |
Why?
| | Hep G2 Cells | 2 | 2019 | 67 | 0.140 |
Why?
| | Autophagy | 1 | 2019 | 284 | 0.130 |
Why?
| | Inflammation | 4 | 2019 | 2837 | 0.130 |
Why?
| | Estradiol | 1 | 2020 | 521 | 0.130 |
Why?
| | Cell Death | 2 | 2024 | 374 | 0.130 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 12 | 0.130 |
Why?
| | Fatty Liver, Alcoholic | 1 | 2016 | 15 | 0.130 |
Why?
| | Fibroblasts | 4 | 2012 | 996 | 0.120 |
Why?
| | Transcription Factor TFIIIB | 1 | 1995 | 1 | 0.120 |
Why?
| | Hydatidiform Mole | 1 | 2015 | 4 | 0.120 |
Why?
| | Animals, Newborn | 4 | 2024 | 844 | 0.120 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 1995 | 21 | 0.120 |
Why?
| | Genomic Imprinting | 1 | 2015 | 26 | 0.120 |
Why?
| | Molecular Sequence Data | 6 | 2003 | 2900 | 0.120 |
Why?
| | Cells, Cultured | 6 | 2022 | 4193 | 0.120 |
Why?
| | Syndrome | 2 | 2007 | 358 | 0.120 |
Why?
| | Obesity | 3 | 2024 | 2992 | 0.120 |
Why?
| | Brain | 4 | 2024 | 2668 | 0.120 |
Why?
| | Diet | 3 | 2011 | 1278 | 0.110 |
Why?
| | PTEN Phosphohydrolase | 1 | 2016 | 167 | 0.110 |
Why?
| | Host Cell Factor C1 | 1 | 2014 | 15 | 0.110 |
Why?
| | RNA, Messenger | 4 | 2014 | 2833 | 0.110 |
Why?
| | Child, Preschool | 5 | 2020 | 11074 | 0.110 |
Why?
| | Cysteine Dioxygenase | 1 | 2014 | 3 | 0.110 |
Why?
| | Carboxy-Lyases | 1 | 2014 | 8 | 0.110 |
Why?
| | Escherichia coli | 4 | 2002 | 815 | 0.110 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 1994 | 18 | 0.110 |
Why?
| | Cell Transformation, Viral | 1 | 1994 | 25 | 0.110 |
Why?
| | Triglycerides | 5 | 2018 | 524 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 465 | 0.110 |
Why?
| | Fetal Growth Retardation | 1 | 2020 | 565 | 0.110 |
Why?
| | Li-Fraumeni Syndrome | 1 | 1994 | 14 | 0.110 |
Why?
| | Protein Denaturation | 2 | 2012 | 74 | 0.110 |
Why?
| | DNA Methylation | 2 | 2018 | 643 | 0.110 |
Why?
| | Sulfurtransferases | 1 | 2013 | 10 | 0.110 |
Why?
| | Glutaredoxins | 1 | 2013 | 13 | 0.110 |
Why?
| | Base Sequence | 6 | 2003 | 2181 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2018 | 605 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 143 | 0.100 |
Why?
| | Liver Diseases, Alcoholic | 1 | 2014 | 93 | 0.100 |
Why?
| | Cell Line | 3 | 2019 | 2847 | 0.100 |
Why?
| | Peroxiredoxins | 1 | 2013 | 24 | 0.100 |
Why?
| | Aldehydes | 1 | 2014 | 145 | 0.100 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 168 | 0.100 |
Why?
| | Cholesterol | 2 | 2013 | 410 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 346 | 0.100 |
Why?
| | Cognition | 2 | 2012 | 1153 | 0.100 |
Why?
| | Blotting, Western | 2 | 2014 | 1226 | 0.100 |
Why?
| | Adult | 6 | 2020 | 37929 | 0.100 |
Why?
| | Tunicamycin | 1 | 2012 | 12 | 0.100 |
Why?
| | Avoidance Learning | 2 | 2012 | 76 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2015 | 430 | 0.100 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2012 | 19 | 0.100 |
Why?
| | Galantamine | 1 | 2011 | 2 | 0.090 |
Why?
| | Fragile X Mental Retardation Protein | 2 | 2009 | 50 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 976 | 0.090 |
Why?
| | Lyases | 1 | 2012 | 12 | 0.090 |
Why?
| | Palmitic Acid | 1 | 2011 | 41 | 0.090 |
Why?
| | Young Adult | 3 | 2020 | 13209 | 0.090 |
Why?
| | Zebrafish Proteins | 1 | 2014 | 288 | 0.090 |
Why?
| | Metabolomics | 1 | 2017 | 678 | 0.090 |
Why?
| | Necrosis | 1 | 2012 | 246 | 0.090 |
Why?
| | Promoter Regions, Genetic | 4 | 2005 | 1250 | 0.090 |
Why?
| | Child | 4 | 2019 | 21935 | 0.090 |
Why?
| | Infant | 6 | 2019 | 9465 | 0.090 |
Why?
| | Chemokine CCL4 | 1 | 2011 | 23 | 0.090 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2013 | 197 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2014 | 860 | 0.090 |
Why?
| | Hypoxia | 1 | 2018 | 1112 | 0.090 |
Why?
| | Methylation | 1 | 2011 | 230 | 0.090 |
Why?
| | Sucrose | 1 | 2011 | 110 | 0.090 |
Why?
| | Neuroblastoma | 1 | 2012 | 160 | 0.090 |
Why?
| | Proteins | 2 | 2013 | 1009 | 0.090 |
Why?
| | Dietary Fats | 1 | 2013 | 304 | 0.090 |
Why?
| | Interleukin-1alpha | 1 | 2011 | 58 | 0.090 |
Why?
| | Adolescent | 3 | 2019 | 21513 | 0.090 |
Why?
| | Stem Cell Transplantation | 1 | 2012 | 176 | 0.090 |
Why?
| | Kinetics | 4 | 2020 | 1670 | 0.090 |
Why?
| | Placenta | 2 | 2015 | 750 | 0.090 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2010 | 41 | 0.080 |
Why?
| | Interleukin-17 | 1 | 2011 | 119 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2011 | 3412 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2014 | 771 | 0.080 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2011 | 137 | 0.080 |
Why?
| | Serine Endopeptidases | 1 | 2010 | 123 | 0.080 |
Why?
| | Blood Coagulation | 1 | 2011 | 255 | 0.080 |
Why?
| | Hemostasis | 1 | 2010 | 82 | 0.080 |
Why?
| | HEK293 Cells | 1 | 2012 | 730 | 0.080 |
Why?
| | Cell Division | 2 | 2002 | 794 | 0.080 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2009 | 22 | 0.080 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 2 | 2024 | 57 | 0.080 |
Why?
| | Acetylcysteine | 1 | 2010 | 145 | 0.080 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 153 | 0.080 |
Why?
| | Restraint, Physical | 1 | 2009 | 72 | 0.080 |
Why?
| | Electroshock | 1 | 2009 | 142 | 0.080 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2007 | 375 | 0.080 |
Why?
| | Hypertriglyceridemia | 1 | 2009 | 39 | 0.080 |
Why?
| | Swimming | 1 | 2009 | 51 | 0.080 |
Why?
| | Alcohol Drinking | 1 | 2016 | 828 | 0.080 |
Why?
| | Pregnancy | 6 | 2020 | 6763 | 0.080 |
Why?
| | Tumor Cells, Cultured | 3 | 2002 | 955 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2013 | 415 | 0.080 |
Why?
| | Hippocampus | 2 | 2012 | 895 | 0.070 |
Why?
| | Karyotyping | 2 | 2006 | 104 | 0.070 |
Why?
| | Genetic Variation | 1 | 2013 | 991 | 0.070 |
Why?
| | Blood Coagulation Disorders | 1 | 2010 | 173 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2012 | 496 | 0.070 |
Why?
| | Embryonic Development | 2 | 2006 | 119 | 0.070 |
Why?
| | Rats | 4 | 2011 | 5647 | 0.070 |
Why?
| | Corticosterone | 1 | 2009 | 236 | 0.070 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 316 | 0.070 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2607 | 0.070 |
Why?
| | Exploratory Behavior | 1 | 2008 | 92 | 0.070 |
Why?
| | Fibrosis | 1 | 2010 | 552 | 0.070 |
Why?
| | Memory | 1 | 2009 | 248 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 32 | 0.070 |
Why?
| | Taste | 1 | 2009 | 229 | 0.070 |
Why?
| | Aging | 3 | 2012 | 1864 | 0.070 |
Why?
| | Lamin Type A | 1 | 2007 | 49 | 0.070 |
Why?
| | Attention | 1 | 2010 | 427 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2011 | 778 | 0.070 |
Why?
| | Glutamine | 1 | 2007 | 103 | 0.070 |
Why?
| | Nerve Tissue Proteins | 1 | 2010 | 596 | 0.060 |
Why?
| | Point Mutation | 1 | 2007 | 235 | 0.060 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2006 | 36 | 0.060 |
Why?
| | Pedigree | 1 | 2007 | 514 | 0.060 |
Why?
| | Glucose-6-Phosphatase | 1 | 2005 | 33 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 570 | 0.060 |
Why?
| | Placental Circulation | 1 | 2006 | 71 | 0.060 |
Why?
| | Arginine | 1 | 2007 | 271 | 0.060 |
Why?
| | Social Behavior | 1 | 2008 | 287 | 0.060 |
Why?
| | Chromosome Banding | 1 | 2005 | 19 | 0.060 |
Why?
| | Cloning, Molecular | 3 | 2001 | 534 | 0.060 |
Why?
| | Amino Acid Sequence | 3 | 2014 | 2139 | 0.060 |
Why?
| | Emotions | 1 | 2010 | 548 | 0.060 |
Why?
| | Models, Biological | 1 | 2012 | 1783 | 0.060 |
Why?
| | Neovascularization, Physiologic | 1 | 2006 | 179 | 0.060 |
Why?
| | Sp3 Transcription Factor | 1 | 2003 | 5 | 0.050 |
Why?
| | Serum Albumin | 1 | 2004 | 150 | 0.050 |
Why?
| | Alanine Transaminase | 2 | 2016 | 157 | 0.050 |
Why?
| | Trophoblasts | 1 | 2006 | 199 | 0.050 |
Why?
| | Hydrocephalus | 1 | 2024 | 106 | 0.050 |
Why?
| | Organ Specificity | 1 | 2003 | 305 | 0.050 |
Why?
| | DNA Primers | 3 | 2005 | 515 | 0.050 |
Why?
| | Blood Physiological Phenomena | 1 | 2002 | 13 | 0.050 |
Why?
| | Carbon-Carbon Ligases | 1 | 2002 | 2 | 0.050 |
Why?
| | Biopolymers | 1 | 2002 | 31 | 0.050 |
Why?
| | Repressor Proteins | 1 | 2006 | 427 | 0.050 |
Why?
| | DNA, Complementary | 2 | 2000 | 272 | 0.050 |
Why?
| | Propionates | 1 | 2002 | 39 | 0.050 |
Why?
| | Enzyme Stability | 1 | 2002 | 70 | 0.050 |
Why?
| | Cricetulus | 1 | 2002 | 109 | 0.050 |
Why?
| | Reperfusion Injury | 1 | 2004 | 279 | 0.050 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2002 | 87 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2000 | 385 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2012 | 1809 | 0.050 |
Why?
| | Cricetinae | 1 | 2002 | 289 | 0.050 |
Why?
| | Genotype | 1 | 2007 | 1916 | 0.050 |
Why?
| | Green Fluorescent Proteins | 2 | 2014 | 390 | 0.050 |
Why?
| | United States | 1 | 2019 | 14841 | 0.050 |
Why?
| | Isoenzymes | 1 | 2002 | 304 | 0.050 |
Why?
| | DNA Mutational Analysis | 1 | 2002 | 399 | 0.040 |
Why?
| | Pyridoxal Phosphate | 1 | 2000 | 24 | 0.040 |
Why?
| | Anxiety | 1 | 2008 | 1035 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2006 | 317 | 0.040 |
Why?
| | Chromosome Mapping | 2 | 2006 | 523 | 0.040 |
Why?
| | Glucose | 1 | 2005 | 1020 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2020 | 60 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 345 | 0.040 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 30 | 0.040 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 19 | 0.040 |
Why?
| | Acidosis, Lactic | 1 | 2020 | 46 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2023 | 622 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2020 | 132 | 0.040 |
Why?
| | Ovariectomy | 1 | 2020 | 152 | 0.040 |
Why?
| | Down-Regulation | 1 | 2002 | 657 | 0.040 |
Why?
| | Homozygote | 1 | 2020 | 203 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 114 | 0.040 |
Why?
| | Catalysis | 1 | 2000 | 307 | 0.040 |
Why?
| | Mice, Mutant Strains | 2 | 2011 | 298 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 124 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 92 | 0.040 |
Why?
| | Lysosomes | 1 | 2019 | 141 | 0.040 |
Why?
| | Sequence Deletion | 2 | 2002 | 183 | 0.040 |
Why?
| | Brain Diseases | 1 | 2020 | 141 | 0.040 |
Why?
| | Progesterone | 1 | 2020 | 254 | 0.040 |
Why?
| | Behavior, Animal | 2 | 2012 | 501 | 0.040 |
Why?
| | Macaca | 1 | 2018 | 56 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 57 | 0.040 |
Why?
| | Gluconeogenesis | 1 | 2018 | 79 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2005 | 1062 | 0.040 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 196 | 0.040 |
Why?
| | Ligands | 1 | 2000 | 664 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2020 | 6079 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 81 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 445 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 285 | 0.040 |
Why?
| | Estrogens | 1 | 2020 | 367 | 0.030 |
Why?
| | Ultraviolet Rays | 1 | 2000 | 396 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 416 | 0.030 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2017 | 44 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2000 | 739 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 621 | 0.030 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 861 | 0.030 |
Why?
| | Gestational Age | 1 | 2020 | 910 | 0.030 |
Why?
| | Alternative Splicing | 1 | 1998 | 229 | 0.030 |
Why?
| | Fatty Acids | 1 | 2019 | 443 | 0.030 |
Why?
| | Protein Carbonylation | 1 | 2016 | 54 | 0.030 |
Why?
| | Hybrid Cells | 1 | 1995 | 49 | 0.030 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 1995 | 18 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 422 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 99 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1738 | 0.030 |
Why?
| | Family | 1 | 2020 | 671 | 0.030 |
Why?
| | Quantitative Trait Loci | 1 | 2018 | 380 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2024 | 1996 | 0.030 |
Why?
| | Genes, Immediate-Early | 1 | 1995 | 21 | 0.030 |
Why?
| | Immediate-Early Proteins | 1 | 1995 | 49 | 0.030 |
Why?
| | Branchial Region | 1 | 2014 | 36 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1710 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2014 | 92 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 59 | 0.030 |
Why?
| | Craniofacial Abnormalities | 1 | 2014 | 72 | 0.030 |
Why?
| | Genes, p53 | 1 | 1994 | 72 | 0.030 |
Why?
| | Body Patterning | 1 | 2014 | 132 | 0.030 |
Why?
| | Vitamin B 12 | 1 | 2014 | 128 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2016 | 437 | 0.030 |
Why?
| | Neural Crest | 1 | 2014 | 118 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 327 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2013 | 33 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 24 | 0.030 |
Why?
| | Atrophy | 1 | 2013 | 184 | 0.030 |
Why?
| | Middle Aged | 2 | 2007 | 33479 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2013 | 303 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 280 | 0.020 |
Why?
| | 3T3-L1 Cells | 1 | 2012 | 36 | 0.020 |
Why?
| | Gene Expression | 1 | 2018 | 1502 | 0.020 |
Why?
| | Alleles | 1 | 2015 | 891 | 0.020 |
Why?
| | Drinking Behavior | 1 | 2012 | 10 | 0.020 |
Why?
| | Enzyme Activation | 2 | 2006 | 810 | 0.020 |
Why?
| | Thermogenesis | 1 | 2012 | 44 | 0.020 |
Why?
| | Chondrocytes | 1 | 2014 | 212 | 0.020 |
Why?
| | Dentate Gyrus | 1 | 2012 | 37 | 0.020 |
Why?
| | Cell Size | 1 | 2012 | 91 | 0.020 |
Why?
| | Maze Learning | 1 | 2012 | 103 | 0.020 |
Why?
| | Cellular Senescence | 1 | 1994 | 189 | 0.020 |
Why?
| | Neuroimmunomodulation | 1 | 2012 | 65 | 0.020 |
Why?
| | Activating Transcription Factor 4 | 1 | 2012 | 20 | 0.020 |
Why?
| | Organ Size | 1 | 2013 | 477 | 0.020 |
Why?
| | Nootropic Agents | 1 | 2011 | 27 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1995 | 405 | 0.020 |
Why?
| | Insulin | 1 | 2002 | 2409 | 0.020 |
Why?
| | Transfection | 1 | 1994 | 945 | 0.020 |
Why?
| | Cell Count | 1 | 2012 | 324 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 257 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2011 | 269 | 0.020 |
Why?
| | Odorants | 1 | 2011 | 109 | 0.020 |
Why?
| | Signal Transduction | 2 | 2016 | 5079 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2012 | 232 | 0.020 |
Why?
| | Adiponectin | 1 | 2013 | 244 | 0.020 |
Why?
| | Stem Cells | 1 | 2014 | 594 | 0.020 |
Why?
| | Cell Movement | 1 | 2014 | 967 | 0.020 |
Why?
| | Zebrafish | 1 | 2014 | 499 | 0.020 |
Why?
| | Computer Simulation | 1 | 2014 | 978 | 0.020 |
Why?
| | Binding Sites | 2 | 2006 | 1303 | 0.020 |
Why?
| | Sinus of Valsalva | 1 | 2009 | 10 | 0.020 |
Why?
| | Time Factors | 1 | 2000 | 6828 | 0.020 |
Why?
| | Random Allocation | 1 | 2010 | 353 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1316 | 0.020 |
Why?
| | Cohort Studies | 1 | 2020 | 5742 | 0.020 |
Why?
| | Apolipoproteins E | 1 | 2009 | 83 | 0.020 |
Why?
| | Models, Molecular | 1 | 2014 | 1570 | 0.020 |
Why?
| | Lactation | 1 | 2010 | 181 | 0.020 |
Why?
| | Immunoblotting | 1 | 2009 | 308 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1120 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2009 | 203 | 0.020 |
Why?
| | Visual Perception | 1 | 2010 | 160 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2004 | 2486 | 0.020 |
Why?
| | Protein Binding | 1 | 2014 | 2224 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 3566 | 0.020 |
Why?
| | Transcription, Genetic | 2 | 2006 | 1457 | 0.020 |
Why?
| | Choline Deficiency | 1 | 2007 | 11 | 0.020 |
Why?
| | Acute-Phase Reaction | 1 | 2007 | 41 | 0.020 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2007 | 31 | 0.020 |
Why?
| | Time | 1 | 2007 | 83 | 0.020 |
Why?
| | Transcription Factor CHOP | 1 | 2007 | 31 | 0.020 |
Why?
| | eIF-2 Kinase | 1 | 2007 | 31 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2007 | 29 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2008 | 431 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2007 | 162 | 0.020 |
Why?
| | Lipase | 1 | 2007 | 69 | 0.020 |
Why?
| | Sequence Analysis, Protein | 1 | 2006 | 30 | 0.020 |
Why?
| | Tyrosine | 1 | 2007 | 222 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2007 | 240 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2012 | 922 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1272 | 0.020 |
Why?
| | Solvents | 1 | 2006 | 109 | 0.020 |
Why?
| | Placentation | 1 | 2006 | 45 | 0.020 |
Why?
| | Snail Family Transcription Factors | 1 | 2006 | 17 | 0.020 |
Why?
| | Blotting, Southern | 1 | 2006 | 73 | 0.020 |
Why?
| | Gene Duplication | 1 | 2006 | 68 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2009 | 518 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2828 | 0.020 |
Why?
| | Nucleic Acid Hybridization | 1 | 2006 | 190 | 0.010 |
Why?
| | Executive Function | 1 | 2010 | 451 | 0.010 |
Why?
| | Tetralogy of Fallot | 1 | 2006 | 79 | 0.010 |
Why?
| | Aorta | 1 | 2007 | 417 | 0.010 |
Why?
| | Alzheimer Disease | 1 | 2010 | 560 | 0.010 |
Why?
| | Rats, Wistar | 1 | 2005 | 455 | 0.010 |
Why?
| | Mothers | 1 | 2010 | 754 | 0.010 |
Why?
| | Kidney | 1 | 2012 | 1468 | 0.010 |
Why?
| | NF-kappa B | 1 | 2007 | 691 | 0.010 |
Why?
| | Triamcinolone | 1 | 2002 | 17 | 0.010 |
Why?
| | Body Weight | 1 | 2007 | 985 | 0.010 |
Why?
| | Liver Neoplasms, Experimental | 1 | 2002 | 31 | 0.010 |
Why?
| | Biotinylation | 1 | 2002 | 32 | 0.010 |
Why?
| | Holoenzymes | 1 | 2002 | 24 | 0.010 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2002 | 24 | 0.010 |
Why?
| | Dimerization | 1 | 2002 | 199 | 0.010 |
Why?
| | Mutagenesis | 1 | 2002 | 179 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1759 | 0.010 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2002 | 195 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2001 | 207 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2002 | 665 | 0.010 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2002 | 362 | 0.010 |
Why?
| | Minisatellite Repeats | 1 | 1998 | 42 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1998 | 155 | 0.010 |
Why?
| | Hot Temperature | 1 | 2001 | 391 | 0.010 |
Why?
| | Alu Elements | 1 | 1998 | 28 | 0.010 |
Why?
| | Exons | 1 | 1998 | 355 | 0.010 |
Why?
| | Liver Neoplasms | 1 | 2002 | 786 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2010 | 10811 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1998 | 812 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1998 | 660 | 0.010 |
Why?
| | Tristetraprolin | 1 | 1995 | 8 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2002 | 1291 | 0.010 |
Why?
| | Blood Glucose | 1 | 2002 | 2186 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|